Abstract: This invention relates to a novel class of partial or full muscarinic receptor agonists intermediates for their preparation, and pharmaceutical compositions and methods of use for the treatment or prevention of diseases the treatment or prevention of which is mediated by muscarinic receptor agonism.
Type:
Grant
Filed:
April 30, 1997
Date of Patent:
July 25, 2000
Inventors:
Anabella Villalobos, Daniel Yohannes, Jolanta Nowakowski, Dane R. Liston